Schedule 13D ownership disclosure

AEON Biopharma, Inc.

Common Stock, $0.0001 par value per share · CUSIP: 00775E102

Event date: 2025-03-24

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Daewoong Co.,Ltd. ("DWC")Reported CIK 0001985493

    Shares: 91,357.00 · Class: 0.9%

  • Daewoong Pharmaceutical Co. Ltd ("DWP")

    Shares: 33,334.00 · Class: 0.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-26-009785
Form type
SCHEDULE 13D/A
Filer
AEON Biopharma, Inc.
CIK
CIK 1837607
Filed
Jan 29, 2026
Reporting period
Mar 24, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub